Comparing sodium-glucose cotransporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors on new-onset depression: a propensity score-matched study in hong kong

HIGHLIGHTS

• who: Jonathan V. Mui from the Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China have published the article: Comparing sodium-glucose cotransporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors on new-onset depression: a propensity score-matched study in Hong Kong, in the Journal: (JOURNAL)
• what: This study investigated the risk of new onset depression between SGLT2I and dipeptidyl peptidase 4 inhibitor (DPP4I) users. The aim of this study is to explore the largely unknown association with depression of SGLT2I use as compared against DPP4I, using a large database . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.